Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
10/2005
10/27/2005US20050239899 Beta-secretase inhibitors
10/27/2005US20050239860 Substituted 5-membered polycyclic compounds useful for selective inhibition of the coagulation cascade
10/27/2005US20050239828 Spirocyclic amides as cannabinoid receptor modulators
10/27/2005US20050239802 E.g., 6-{2-[5-Chloro-2-(2,4-difluorobenzyloxy)- phenyl]cyclopent-1-enyl}-pyridine-2-carboxylic acid, used to treat prostaglandin mediated diseases that include inflammatory, neuropathic or visceral pain
10/27/2005US20050239791 Substituted 1-heteroaryl-4-substituted piperazine and piperidine analogues
10/27/2005US20050239765 Half-sandwich ruthenium (II) compounds comprising nitrogen containing ligands for treatment of cancer
10/27/2005US20050239684 Compounds which inhibit beta-secretase activity and methods of use thereof
10/27/2005US20050239656 Pyridine compounds or salts thereof and herbicides containing the same
10/27/2005US20050239655 3-heterocyclyl substituted benzoic acid derivatives
10/27/2005US20050239054 Drug screening compounds having esterified phosphonate or carboxyl groups with novel enzyme GS-7340 Ester Hydrolase and identifying the compound as a suitable prodrug by the formation of a phosphonic acid or carboxylic acid; candidate compounds
10/27/2005US20050238916 Light sources comprising organic light emmiters between electrodes, used in displaying, electrophotography, recording, exposure, signs or optical communications; brightness; efficiency; durability; iridium complex
10/27/2005US20050236980 Charge transport compositions and electronic devices made with such compounds
10/27/2005DE102004018043A1 Preparation of diimine compounds useful as ligands for transition metal catalyst, involves reacting dicarbonyl compounds with primary amines in presence of phosphorous pentoxide
10/27/2005CA2563291A1 4-cyano-phenoxy-alkyl carboxyl derivatives as androgen modulators
10/27/2005CA2563225A1 Process for preparing pyridazinone compounds
10/27/2005CA2562378A1 Use of pyridindione derivatives for protecting organic material against detrimental effects of light
10/27/2005CA2562369A1 Condensed pyridine derivatives useful as a28 adenosine receptor antagonists
10/27/2005CA2562244A1 Cyclic compounds
10/27/2005CA2562082A1 Cetp inhibitors for the treatment and prevention of atherosclerosis
10/27/2005CA2560346A1 Polycyclic pyridines as potassium ion channel modulators
10/26/2005EP1589013A2 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines with adenosine receptor-binding activity and their use as cardiovascular preparations
10/26/2005EP1589012A2 N-alkylheteroaryl secondary para-phenyldiamine, dyeing composition containing the same, process for making it and uses thereof
10/26/2005EP1589000A2 (R)-Chiral halogenated 1-substitutedamino-(N+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity
10/26/2005EP1588707A1 Stable solid medicinal composition for oral administration
10/26/2005EP1587473A2 Thiosemicarbazones as anti-virals and immunopotentiators
10/26/2005EP1347952A4 Aryl and heteroarylcyclopropyl oxime ethers and their use as fungicides
10/26/2005EP1183229B1 Glucagon antagonists/inverse agonists
10/26/2005EP1098870B1 Nitrate salt of Cetirizine
10/26/2005EP1070053B1 Synthesis of 3-amino-2-chloro-4-methylpyridine from acetone and ethyl cyanoacetate
10/26/2005EP1034793B1 Preventives/remedies for glaucoma
10/26/2005EP0973727B1 Activated iododerivatives for the treatment of cancer and aids
10/26/2005EP0835245B1 Substituted n-methylenethioureas as pesticides
10/26/2005CN1688548A Process for preparing quinolin antibiotic intermediates
10/26/2005CN1688546A Pyridinyl amides and imides for use as fungicides
10/26/2005CN1688545A Phosphodiesterase 4 inhibitors, including n-substituted phenylamine and diphenylamine analogs
10/26/2005CN1688540A Novel vinyl carboxylic acid derivatives and their therapeutical use
10/26/2005CN1224632C Polymerisation catalysts
10/26/2005CN1224616C Processes for preparing pesticidal intermediates
10/26/2005CN1224615C Process for preparation of trimethylpyridine and 2, 3, 5, 6-tetramethylpyridine
10/26/2005CN1224609C Process for preparation of arylethanolamine derivatives having anti-obesity and anti-diabetic properties
10/26/2005CN1224388C Modified prodrug forms of ap/amp
10/25/2005US6958400 Extruding through an orifice, cooling to form granule; chemical intermediates to form 4-dimethylaminopyridine catalyst, use for catalyzing acylation reactions in the pharmaceutical and agricultural industries
10/25/2005US6958399 Compounds capable of activating cholinergic receptors
10/25/2005US6958373 Transformation of polymers to useful chemicals oxidation
10/25/2005US6958352 Compounds for inhibiting insulin secretion and methods related thereto
10/25/2005US6958333 N'-(isoindolino[3,2-b]perhydro-1,3-oxazin-5-on-9-yl)-N-(pyridin-2-yl) urea, for example; cyclin-dependent kinase inhibitors; colon cancer treatment
10/25/2005US6958331 sulfonyl amine derivatives such as {2-(2,2-diphenyl-ethylamino)-5-[4-(4-isopropyl-piperazine-1-carbonyl)-piperidine-1-sulfonyl]-phenyl}-morpholin-4-yl-methanone; pain, inflammation, septic shock
10/25/2005CA2331053C Compositions and methods for treating conditions responsive to estrogen
10/25/2005CA2331009C Compositions and methods of treatment for conditions responsive to testosterone elevation
10/25/2005CA2157191C Process for the hydrogenation of imines
10/25/2005CA2147056C Novel delta-amino-gamma-hydroxy-omega-aryl-alkanoic acid amides
10/20/2005WO2005097779A1 Diarylamine derivatives as calcium channel blockers
10/20/2005WO2005097751A2 Non-imidazole heterocyclic compounds as histamine h3-receptor ligands
10/20/2005WO2005097750A1 Substituted pyridones as inhibitors of poly(adp-ribose) polymerase (parp)
10/20/2005WO2005097749A1 Alkyl pyridinium dicyanamides and method for the production thereof
10/20/2005WO2005097748A1 Process for producing 2-(phenyl methyl thio)-3-pyridine carboxylic acid
10/20/2005WO2005097747A1 Histone deacetylase inhibitor prodrugs
10/20/2005WO2005097746A2 2-propene-1-ones as hsp 70 inducers
10/20/2005WO2005097738A1 Novel sulfonamide derivative
10/20/2005WO2005097733A1 Process for the preparation of enantiomerically enriched beta amino acid derivatives
10/20/2005WO2005097713A1 Fluoridation method
10/20/2005WO2005097712A2 Process for preparing diimine compounds
10/20/2005WO2005070891A3 Compounds and methods of use
10/20/2005WO2005070888A3 Process for the manufacture of 2,3-dichloropyridine
10/20/2005WO2005066129A3 Bis-pyridino containing compounds for use in the treatment of cns pathologies
10/20/2005WO2005061450A3 Hiv protease inhibiting sulfonamides
10/20/2005WO2005055715A3 Insecticidal n-(heteroarylalkyl) alkanediamine derivatives
10/20/2005US20050234265 2-aminomethyl-5-tert-butyl-3-phenylphenol; antimalaria; used against protozoa of the genus Plasmodium, particularly emerging strains of drug-resistant Plasmodia
10/20/2005US20050234239 Method of forming a carbon-carbon or carbon-heteroatom linkage
10/20/2005US20050234236 Process for preparing pyridazinone compounds
10/20/2005US20050234232 Novel compositions for the delivery of negatively charged molecules
10/20/2005US20050234131 Novel ligand antagonists of RAR receptors and pharmaceutical/cosmetic applications thereof
10/20/2005US20050234125 Alpha-sulfonylamino-acetonitriles
10/20/2005US20050234110 Fungicides; N-{2-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]ethyl}-2-trifluoromethylbenzamide; -{2-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]ethyl}-2-iodobenzamide; -{2-[3-chloro-5-(trifluoromethyl)-2-pyridinyl]ethyl}-2-bromobenzamide
10/20/2005US20050234109 to treat Alzheimer's disease,Down syndrome and the other diseases associated with amyloid deposition; thiomethane, sulfinylmethane or sulfonylmethane compounds; 5-Chloro-4-[(4-chlorophenylsulfonyl)-(2,5-difluorophenyl)methyl]-2-(4'-hydroxypiperidin-1'-yl)pyridine
10/20/2005US20050234106 1-aryl-1-heteroarylaminoalkylene-substituted, e.g., 1-[fluorophenylcyclohexylmethyl]isoquinolin-1-ylamine; antiarrhythmia agents; cardiovascular disorders
10/20/2005US20050234101 Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds
10/20/2005US20050234065 Dipeptidyl peptidase-IV inhibitors
10/20/2005US20050234061 N-[3-(4-chlorophenyl)-2-(3-pyridyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists
10/20/2005US20050234058 Secondary amino-and cycloamino-cycloalkanol derivatives and methods of their use
10/20/2005US20050234046 Aryl sulfonamide and sulfonyl compounds as modulators of PPAR and methods of treating metabolic disorders
10/20/2005US20050234045 N-alkyl-4-methyleneamino-3-hydroxy-2-pyridones
10/20/2005US20050233234 Electroluminescent platinum compounds and devices made with such compounds
10/20/2005US20050232928 Drug conjugates
10/20/2005US20050232915 Matrix metalloproteinase inhibitors in combination with hypothermia and/or radiotherapy for the treatment of cancer
10/20/2005CA2563205A1 Alkylpyridinium dicyanamides and method for the production thereof
10/20/2005CA2562371A1 Diarylamine derivatives as calcium channel blockers
10/20/2005CA2561973A1 Process for the preparation of enantiomerically enriched beta amino acid derivatives
10/20/2005CA2561791A1 Non-imidazole heterocyclic compounds
10/20/2005CA2561617A1 Histone deacetylase inhibitor prodrugs
10/20/2005CA2561280A1 Substituted pyridones as inhibitors of poly(adp-ribose) polymerase (parp)
10/19/2005EP1586578A2 Method of removing allyl series protecting group using novel ruthenium complex and method of synthesizing allyl ethers
10/19/2005EP1586559A1 Biaryl-methanethio-, -sulphinyl- and sulphonyl derivatives
10/19/2005EP1586558A2 Bis-sulfonamide hydroxyethylamino retroviral protease inhinitors
10/19/2005EP1585735A1 Hydroxamid acid derivatives as histone deacetylase (hdac) inhibitors
10/19/2005EP1585730A1 Carboxamide derivatives and their use as factor xa inhibitors
10/19/2005EP1585725A2 Compounds which mimic the chemical and biological properties of discodermolide
10/19/2005EP1585521A2 Derivatives of aryl-quinazoline/aryl-2amino-phenyl methanone which promote the release of parathyroid hormone
10/19/2005EP1585511A2 Asthma and allergic inflammation modulators
10/19/2005EP1463714A4 Vanilloid receptor ligands and their use in treatments
1 ... 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 ... 633